RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.

Melissa Lavasani And “Whiz” Buckley On Psychedelic Trends In 2025

Happy Black Friday, and in this special Trade To Black episode, Melissa Lavasani, CEO of Psychedelic Medicine, and former Top Gun Fighter Pilot Matthew “Whiz”

November 29, 2024

Paris Hilton backs California bill requiring sunshine on ‘troubled teen industry’

Celebrity hotel heiress Paris Hilton is backing California lawmakers’ push to increase the transparency of residential teen therapeutic centers by requiring these programs to report

April 17, 2024

CinRx raises $73M to create more biotechs, further support obesity drug development

CinRx Pharma, the creator of biotechs like CinCor, which was acquired by AstraZeneca, raised another $73 million to support its current portfolio … Sign up

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.